Using CADD tools to inhibit the overexpressed genes FAP, FN1, and MMP1 by repurposing ginsenoside C and Rg1 as a treatment for oral cancer

• Manal Abouelwafa,
• Tamer M. Ibrahim,
• Tamer M. Ibrahim,
• Mohamed S. El-Hadidi,
• Mater H. Mahnashi,
• Amani Y. Owaidah,
• Nizar H. Saeedi,
• Hany G. Attia,
• John J. Georrge,
• Amany Mostafa

Affiliations

Manal Abouelwafa

Department of Bioinformatics, Christ College, Rajkot, Gujarat, India

Tamer M. Ibrahim

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

Tamer M. Ibrahim

Bioinformatics Group, Center for Informatics Sciences, School of Information Technology and Computer Science, Nile University, Giza, Egypt

Mohamed S. El-Hadidi

Bioinformatics Group, Center for Informatics Sciences, School of Information Technology and Computer Science, Nile University, Giza, Egypt

Mater H. Mahnashi

Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia

Amani Y. Owaidah

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia

Nizar H. Saeedi

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia

Hany G. Attia

Department of Pharmacognosy, College of Pharmacy, Najran University, Najran, Saudi Arabia

John J. Georrge

Department of Bioinformatics, University of North Bengal, West Bengal, India

Amany Mostafa

Nanomedicine and Tissue Engineering Laboratory, Medical Research Centre of Excellence, National Research Centre (NRC), Cairo, Egypt